How I treat acquired aplastic anemia
A Bacigalupo - Blood, The Journal of the American Society of …, 2017 - ashpublications.org
Acquired severe aplastic anemia (SAA) is a rare hematologic disease associated with
significant morbidity and mortality. Immune destruction of hemopoietic stem cells plays an …
significant morbidity and mortality. Immune destruction of hemopoietic stem cells plays an …
Indications for allo-and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
This is the sixth special report that the European Society for Blood and Marrow
Transplantation regularly publishes on the current practice and indications for …
Transplantation regularly publishes on the current practice and indications for …
Risk factors for acute GVHD and survival after hematopoietic cell transplantation
M Jagasia, M Arora, MED Flowers… - Blood, The Journal …, 2012 - ashpublications.org
Risk factors for acute GVHD (AGVHD), overall survival, and transplant-related mortality were
evaluated in adults receiving allogeneic hematopoietic cell transplants (1999-2005) from …
evaluated in adults receiving allogeneic hematopoietic cell transplants (1999-2005) from …
Guidelines for the diagnosis and management of aplastic anaemia.
JCW Marsh, SE Ball, J Cavenagh… - British journal of …, 2009 - search.ebscohost.com
The article presents the guideline for the diagnosis and management of aplastic anaemia. It
aims to provide healthcare professionals with clear guidance on the diagnosis and …
aims to provide healthcare professionals with clear guidance on the diagnosis and …
Aplastic anemia
NS Young - New England Journal of Medicine, 2018 - Mass Medical Soc
Aplastic Anemia | New England Journal of Medicine Skip to main content The New England
Journal of Medicine homepage Advanced Search SEARCH The New England Journal of …
Journal of Medicine homepage Advanced Search SEARCH The New England Journal of …
How I treat acquired aplastic anemia
Survival in severe aplastic anemia (SAA) has markedly improved in the past 4 decades
because of advances in hematopoietic stem cell transplantation, immunosuppressive …
because of advances in hematopoietic stem cell transplantation, immunosuppressive …
The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies
JR Passweg, H Baldomero, GW Basak… - Bone marrow …, 2019 - nature.com
Hematopoietic cell transplantation (HCT) is widely used for acquired and congenital
disorders of the hematopoietic system. Number of transplants done in Europe and …
disorders of the hematopoietic system. Number of transplants done in Europe and …
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009
Abstract The European Group for Blood and Marrow Transplantation regularly publishes
special reports on the current practice of haematopoietic SCT for haematological diseases …
special reports on the current practice of haematopoietic SCT for haematological diseases …
Aplastic anemia
Evidence has accumulated in the recent years further corroborating an immune-mediated
process underlying aplastic anemia pathogenesis. Hematopoietic stem-cell transplantation …
process underlying aplastic anemia pathogenesis. Hematopoietic stem-cell transplantation …
Similar outcome of upfront‐unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric …
C Dufour, P Veys, E Carraro… - British journal of …, 2015 - Wiley Online Library
We explored the feasibility of unrelated donor haematopoietic stem cell transplant (HSCT)
upfront without prior immunosuppressive therapy (IST) in paediatric idiopathic severe …
upfront without prior immunosuppressive therapy (IST) in paediatric idiopathic severe …